Polycystin-1 (PC1), encoded by the PKD1 gene that is mutated in the autosomal dominant polycystic kidney disease, regulates a number of processes including bone development. Activity of the transcription factor RunX2, which controls osteoblast differentiation, is reduced in Pkd1 mutant mice but the mechanism governing PC1 activation of RunX2 is unclear. PC1 undergoes regulated cleavage that releases its C-terminal tail (CTT), which translocates to the nucleus to modulate transcriptional pathways involved in proliferation and apoptosis. We find that the cleaved CTT of PC1 (PC1-CTT) stimulates the transcriptional coactivator TAZ (Wwtr1), an essential coactivator of RunX2. PC1-CTT physically interacts with TAZ, stimulating RunX2 transcriptional activity in pre-osteoblast cells in a TAZ-dependent manner. The PC1-CTT increases the interaction between TAZ and RunX2 and enhances the recruitment of the p300 transcriptional co-regulatory protein to the TAZ/RunX2/PC1-CTT complex. Zebrafish injected with morpholinos directed against pkd1 manifest severe bone calcification defects and a curly tail phenotype. Injection of messenger RNA (mRNA) encoding the PC1-CTT into pkd1-morphant fish restores bone mineralization and reduces the severity of the curly tail phenotype. These effects are abolished by co-injection of morpholinos directed against TAZ. Injection of mRNA encoding a dominant-active TAZ construct is sufficient to rescue both the curly tail phenotype and the skeletal defects observed in pkd1-morpholino treated fish. Thus, TAZ constitutes a key mechanistic link through which PC1 mediates its physiological functions.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in the genes that encode polycystin-1 (PC1) and polycystin-2 (PC2). PC1 is an extremely large membrane protein, with a molecular mass exceeding 460 kDa and 11 predicted transmembrane spans (1, 2) . PC1 has been implicated in a variety of signaling pathways (3) (4) (5) , including G-protein signaling, oxygen sensing (6) and the Wnt, AP-1, NFAT and JAK-STAT cascades (7) (8) (9) (10) (11) (12) (13) (14) . The PC2 protein has a predicted molecular weight of ∼110 kDa and six putative membrane spanning regions (15, 16) . PC2 is a Ca 2+ permeable non-selective cation channel and belongs to the transient receptor potential family of cation channels (17, 18) . PC2 is thought to participate in mediating the release of calcium from intracellular stores and may contribute to the transduction of mechanostimulatory sensations communicated via the primary cilium (19, 20) . The 200 amino acid C-terminal cytoplasmic tail of PC1 contains a predicted coiled-coil domain that mediates this protein's interaction with PC2 (21, 22 ). PC2 appears to be involved in several signaling pathways (23, 24) , including those that have been attributed to PC1 (8) .
PC1 is cleaved at sites in both its N-and C-terminal domains (3) . N-terminal cleavage occurs at the G protein-coupled receptor proteolytic (GPS) site, near the first transmembrane domain (25) . This cis-autoproteolytic cleavage occurs as PC1 traverses the secretory pathway and is stimulated by PC2 (25) (26) (27) (28) (29) . The cleaved N-terminus remains non-covalently attached to the membrane-bound C-terminal fragment (30) . Expression of mutant PC1 that cannot undergo GPS cleavage does not rescue the cystic phenotype in PKD1 -/-mice (31) . In addition, a related missense mutation causes ADPKD (25, 31, 32) . At least three other cleavages liberate portions of the cytoplasmic CTT of PC1. One of these cleavages releases a ∼35 kDa soluble portion of the tail that accumulates in the nucleus (33) (34) (35) (36) and that influences transcriptional pathways (10, 12) . Another more distal cleavage releases a 17 kDa fragment that interacts with the transcriptional activators STAT3 and STAT6 and the coactivator p100 (35, 37) . Flow cessation increased this cleavage as well as nuclear translocation of both the PC1 tail (33) and STAT6 (35, 37) . A fragment with six transmembrane domains that regulates store-operated calcium entry (38) has also been identified.
TAZ (transcriptional coactivator with PDZ binding motif ), also known as WWTR1 (WW domain containing transcription factor 1), acts as a transcriptional co-regulatory molecule for a variety of transcription factors. The activities of TAZ and its homolog YAP (Yes-associated protein) are negatively influenced by the Hippo signaling pathway, which is a major regulator of cell proliferation and organ size (39, 40) . Perturbations in Hippo signaling are associated with a variety of tumors (41) , and aberrant Hippo signaling has also been detected in animal models of ADPKD (42) . TAZ reduces the activity of PPARγ to inhibit adipocyte differentiation, it acts to stimulate TEAD/TEF, and it similarly enhances the activity of TTF-1 in the differentiation of respiratory epithelium (43) (44) (45) (46) . TAZ plays a critical role in cell fate-determination during mesenchymal differentiation, where it acts as a switch between adipocyte and osteoblast cell development (47) . TAZ promotes osteoblast differentiation via activation of the transcription factor RunX2 and inhibition of PPARγ (48) . Runx2 is the master transcription factor regulating skeletogenesis, and is essential for directing the differentiation of mesenchymal precursor cells into osteoblasts (49) (50) (51) . Targeted disruption of Runx2 results in the complete loss of bone calcification (50) . Overexpression of RunX2 results in accelerated endochondral ossification due to premature chondrocyte maturation (52) . RunX2 expression is upregulated during chondrocyte differentiation into osteoblasts, but is later downregulated in end-stage mature osteoblasts (53) .
While much remains to be learned about the functions of the polycystin proteins, it is clear that in renal epithelial cells PC1 and PC2 interact with one another and localize together to the primary cilium (54) . This ciliary localization appears to be critically important in aspects of PC1 and 2 function and in preventing cystic disease (55) . Osteoblasts have been shown to possess primary cilia and express both PC1 and 2 (56) . Furthermore, PC1 plays an important role in skeletogenesis via regulation of the bone master transcription factor Runx2 (57).
PC1 is highly expressed in adult cartilage, and Pkd1 knockout mice demonstrated severe skeletal compromise (58, 59 (60) . Selective inactivation of Pkd1 at early stages of osteoblast development is associated with decreased bone formation and increased accumulation of fat in the marrow (61) . A recent study demonstrated that Pkd1 and TAZ compound heterozygotes exhibited additive decrements in bone mineral density, which was attributed to the interaction of TAZ and the cleaved CTT of PC1, leading to increased Runx2-mediated osteogenic expression (62) . TAZ knockout in zebrafish results in complete failure of bone formation, cardiac abnormalities and early embryonic death (48) . Surprisingly, TAZ knockout mice demonstrate only minor defects in skeletogenesis, while other mesenchymalderived tissues, including the kidney and lung, are profoundly disrupted, resulting in the development of polycystic kidney disease and pulmonary emphysema (63) (64) (65) . TAZ knockout mice demonstrate renal cyst formation as early as embryonic day 15.5 with prominently dilated Bowman's capsules, multicystic kidneys, hydronephrosis and severe concentration defects leading to polyuria (64) .
The bone and kidney phenotypes associated with perturbations of both PC1 and TAZ expression suggest the interesting possibility that these proteins may participate together in a common signaling pathway. In the present study we find that PC1 and one of its C-terminal cleavage fragments substantially increase TAZ activity, and with it the activity of the RunX2 transcriptional pathway. We find that TAZ associates with the PC1-CTT to form a functional complex. The interaction between the PC1-CTT and TAZ increases the association between TAZ and RunX2 as well as the recruitment of the p300 transcriptional coregulatory protein to the TAZ/RunX2/PC1-CTT complex. Finally, we show that the PC1-CTT is sufficient to rescue the tail curvature and skeletal defects resulting from loss of pkd1 in zebrafish. This effect requires the presence of TAZ and can be mimicked by the expression of a constitutively active form of TAZ, suggesting that TAZ is a critical downstream component of the cellular machinery through which the PC1 protein mediates its functions.
Results

A coactivator trap screen reveals that TAZ is a positively regulated target of the PC1-CTT
The observation that Pkd1 regulates skeletogenesis via stimulation of RunX2 (57,60) led us to search for novel regulatory targets that could mediate this influence. To identify transcription factors regulated by the PC1-CTT, we employed a 'coactivator trap' screen, in which over 1400 transcription factors are fused to the DNA-binding domain of Gal4 (12, 66) . After co-transfection of each transcription factor-Gal4 construct and a Gal4-driven luciferase reporter vector into HEK293 cells, luciferase assays were performed to establish baseline activities for each transcription factor. The PC1-CTT was then co-transfected and its effect on each transcription factor's activity was measured as a change in luciferase production as compared with each transcription factor's respective baseline level. Transfection with the PC1-CTT NLS construct, which encodes the PC1-CTT lacking the 20 amino acids that encode its putative nuclear localization sequence (NLS), was also performed. PC1-CTT NLS does not enter the nucleus, and thus serves as a negative control for PC1-CTT-associated transcriptional regulatory activity (33) . While the majority of the transcription factors that were affected by PC1-CTT expression exhibited an inhibitory effect (12) , the activities of a smaller subset of transcription factors were stimulated in the presence of the PC1-CTT. Among these the most dramatically stimulated was TAZ/Wwtr1, which showed a 36-fold increase in activity in cells expressing the PC1-CTT as compared with those expressing the PC1-CTT NLS negative control (Supplementary Material, Table S1 ).
To confirm the results of the initial screen the TAZ-Gal4 fusion construct was co-transfected with either PC1-CTT or PC1-CTT NLS into HEK293 cells. Activation of TAZ was measured by Gal4-induced expression of a co-transfected luciferase reporter gene. Expression of the PC1-CTT resulted in a significant increase in TAZ-Gal4 activity, while the PC1-CTT NLS construct had no effect on TAZ-Gal4 luciferase activity (Fig. 1A) . 
PC1 stimulates RunX2 activity via its CTT
TAZ is required for PC1-CTT mediated RunX2 activation
TAZ activity has been extensively characterized in the regulation of bone growth and development, during which it is responsible for directing pluripotent mesenchymal stem cells toward the osteoblastic lineage (via stimulation of RunX2) and away from the adipocyte cell lineage (via inhibition of PPARγ ). Thus, we next set out to investigate the relationship between TAZ and the PC1-CTT in the context of RunX2 activation. Overexpression of FLAG-RunX2 was used to validate the efficacy of the RunX2 reporter construct in the C3H10T 1/2 cells and, as expected, it produced a significant increase in the luciferase signal ( Fig. 2A , right panel). Expression of the PC1-CTT stimulates RunX2 activity, while the PC1-CTT NLS construct has no effect. Consistent with reports in the literature, TAZ expression increases RunX2 activity, while co-expression of TAZ with the PC1-CTT resulted in a further stimulation of in RunX2 activity ( Fig 
The PC1-CTT physically interacts with TAZ
To determine if the PC1-CTT could exert its regulatory effects on TAZ through a physical interaction, we performed coimmunoprecipitation experiments between FLAG-TAZ or FLAG-YAP constructs and hemagglutinin (HA)-tagged PC1-CTT (HA-PC1CTT) expressed in HEK293 cells. FLAG immunoprecipitation (FLAG-IP) demonstrated a clear association between the PC1-CTT and TAZ (Fig. 3A ), but not with YAP, which shares significant sequence homology with TAZ. Using HA-conjugated beads to immunoprecipitate the PC1-CTT, we were able to confirm the TAZ-PC1-CTT interaction (Fig. 3B ). To further refine the interaction site between TAZ and the PC1-CTT we generated a construct containing only the final 91 amino acids of PC1, which includes the coiled-coil domain (p91). Glutathione S-transferases-p91 (GST-p91) was produced in BL21 bacteria, purified on glutathione 4B beads and exposed to lysate from HEK293 cells expressing FLAG-TAZ. Elution of the washed beads revealed GST-p91 in a complex with FLAG-TAZ, suggesting that the final 91 amino acids of PC1 are sufficient to mediate its interaction with TAZ ( Fig. 3C ).
The PC1-CTT does not change exogenous TAZ protein expression levels, 14-3-3 binding or nuclear localization TAZ activity is regulated by phosphorylation at a number of sites that influence its stability and subcellular localization (44) . Phosphorylation by Casein Kinase 1 at Ser314 targets TAZ for interaction with the SCF E3 ubiquitin ligase and degradation. TAZ phosphorylated at Ser89 interacts with 14-3-3, which prevents it from being translocated into the nucleus and results in its accumulation in the cytosol. We wondered whether association with the PC1-CTT might enhance the activity of TAZ by blocking its interaction with 14-3-3, by preventing its degradation or by directly inducing the nuclear translocation of TAZ through the activity of the PC1-CTT protein's intrinsic NLS. To address these possibilities, HEK293 cells were transfected with FLAG-TAZ alone or together with HA-PC1-CTT. Expressed alone, TAZ demonstrates a robust interaction with 14-3-3 ( Fig. 3D ) and exhibits a primarily cytoplasmic localization (Fig. 4) , in agreement with published reports (44) . Co-expression of TAZ with the PC1-CTT did not increase levels of exogenous TAZ protein expression (Fig. 3D) . Furthermore, PC1 co-expression did not result in a significant change in TAZ binding to 14-3-3, nor did it cause TAZ to redistribute into the nucleus (Figs 3D and 4). In addition, endogenous RunX2 levels were not altered by the expression of the HA-PC1-CTT, of TAZ or of both of these proteins together (Supplementary Material, Fig.1 ). Mutation of TAZ serine 89 to alanine results in the production of a dominant-active TAZ(S89A) construct, which is predominantly located in the nucleus (44) . TAZ(S89A) shows no interaction with 14-3-3 but binds to the PC1-CTT at similar levels as does the WT TAZ (Fig. 3D) . TAZ(S89A) expression simulates a 1.5-fold increase in RunX2-Luc activity, consistent with its nuclear localization. Co-expression of TAZ(S89A) with the PC1-CTT results in a further increase of 2.3-fold stimulation of RunX2 activity (Supplementary Material, Fig.2 ). TAZ(S89A) also interacts with the PC1-CTT NLS protein, although apparently at a somewhat lower level than it does with PC1-CTT (Fig. 3D) . Interestingly, expression of TAZ(S89A) together with the construct encoding the PC1-CTT NLS protein resulted in the accumulation within the nucleus of the of the usually non-nuclear PC1-CTT NLS protein (Supplementary Material, Fig.3 ), providing additional evidence for the existence and the functional significance of the interaction between TAZ and the PC1 CTT. Taken together, these data suggest that the PC1-CTT regulates nuclear TAZ activity by a mechanism that does not involve enhancing its expression or inducing the redistribution of TAZ to the nucleus. The transcriptional co-regulatory molecule p300 is required for the stimulatory effects of the PC1-CTT on RunX2 activity
The PC1-CTT does not appear to stimulate TAZ activity by enhancing its nuclear entry. The ubiquitously expressed transcriptional co-regulatory protein p300 has been reported to interact with both TAZ and RunX2, and is essential for RunX2 transcriptional activation (70) (71) (72) . Thus, p300 interaction with the TAZ-RunX2 complex may represent a potential point of regulation of TAZ by the PC1-CTT that could alter TAZ activity rather than induce nuclear redistribution of TAZ. To test this hypothesis we knocked down p300 using shRNA with an efficiency of approximately 50% as determined by qRT-PCR Cell lysates were subjected to immunoprecipitation using anti-FLAG sepharose, then blotted with the indicated antibodies. (B) HEK293 cells were co-transfected with FLAG-TAZ and HA-PC1-CTT. Cell lysates were subjected to immunoprecipitation using anti-HA sepharose, then blotted with the indicated antibodies. (C) A GST-tagged construct containing the C-terminal 91 amino acids of the PC1-CTT (p91) was produced in BL21 bacteria and purified on glutathione-sepharose 4B beads. The GST-p91 coated glutathione beads were then exposed to lysates from HEK293 cells expressing FLAG-TAZ and the resulting complexes were blotted with the indicated antibodies.
(D) HEK293 cells were co-transfected with FLAG-TAZ(WT) or FLAG-TAZ(S89A) and HA-PC1-CTT. Cell lysates were subjected to immunoprecipitation using anti-FLAG sepharose, then blotted with the indicated antibodies.
analysis (Fig. 5A ). RunX2-luciferase activity was significantly reduced in cells receiving shRNA against p300, when compared with cells receiving control shRNA. Expression of the PC1-CTT stimulated RunX2 activity in shControl cells. This stimulatory effect, however, was completely abolished in cells with reduced levels of p300 (Fig. 5B) .
Expression of the PC1-CTT increases the extent of the TAZ-RunX2 and the TAZ-p300 interactions
Co-expression of the Abl tyrosine kinase enhances the formation of a stable and functional RunX2-TAZ complex and consequently stimulates osteoblast differentiation (73) . We hypothesized that PC1-CTT might produce its stimulation of RunX2 activity through a similar mechanism, resulting in the formation of a larger quantity of the transcriptionally active RunX2/TAZ/p300 complex. To test this possibility, we performed co-immunoprecipitation experiments from cells transfected to express Myc-tagged p300, FLAG-tagged TAZ and HA-tagged PC1-CTT to assess whether PC1-CTT expression enhanced the association of TAZ with p300. We first performed a control experiment which demonstrated that, in the absence of FLAG-TAZ expression, neither the p300 protein nor the PC1-CTT was recovered in an anti-FLAG immunoprecipitation (Fig. 5C , left blot). When FLAG-TAZ was expressed in the absence of the PC1-CTT, little p300 was detected in complex with TAZ. In contrast, expression of the PC1-CTT resulted in the appearance of a faint but detectable band corresponding to p300 in complex with TAZ (Fig. 5C, right blot) . Quantification of these results demonstrated a significant increase in the association of p300 with TAZ in the presence of the PC1-CTT (Fig. 5C, right panel) . We next assessed the level of complex formation between TAZ and RunX2 in cells that did or did not express the PC1-CTT. Lysates from HEK293 cells co-transfected with RunX2, TAZ and HA-PC1-CTT were subjected to immunoprecipitation with antibodies directed against RunX2 or against the TAZ protein, and the recovered proteins were analyzed by western blot. The quantity of RunX2 that co-precipitated with TAZ ( Fig. 6A ) and the quantity of TAZ that co-precipitated with RunX2 ( Fig. 6B) were both substantially increased in cells that co-expressed the PC-CTT. Overexpression of the PC1-CTT-HA results in an increase in endogenous TAZ expression, which can be observed in the lysate and IP lanes of Figure 6B as a band running slightly below the overexpressed TAZ band. The increased expression of endogenous TAZ in the presence of PC1-CTT likely facilitates immunoprecipitation of RunX2 without the addition of exogenous TAZ (Fig. 6A) .
Morpholino-mediated disruption of Pkd1a/b gene expression in zebrafish results in decreased jaw bone mineralization and curly tails, which can be rescued by expression of the PC1-CTT or of constitutively active TAZ
The phenotype of zebrafish injected with morpholinos directed against pkd1a and pkd1b includes a dramatic upward curling of the tail as well as significant skeletal abnormalities, the most prominent of which is a disruption of jaw bone growth and mineralization (74) . To determine the capacity of the PC1-CTT to rescue the phenotypes associated with impaired pkd1 gene expression in vivo, zebrafish embryos were injected with pkd1a/b morpholinos alone, or in association with mRNA encoding the PC1-CTT or mRNA encoding dominant active TAZ(S89A). Knockdown of pkd1a/b results in a significant decrease in jaw bone mineralization, as assayed by calcein staining at 7 days post fertilization ( Fig. 7A and B) . As expected, knockdown of pkd1a/b also produces significant tail curvature (74, 75) , scored as previously described (12) (Fig. 7C and D) . Concurrent injection of the PC1-CTT restored jaw bone mineralization and suppressed tail curvature in the pkd1a/b knockdown fish. Injection of PC1-CTT mRNA was unable to rescue jaw bone mineralization or tail curvature in pkd1a/b-knockdown zebrafish lacking expression of TAZ. Expression of dominant active TAZ(S89A) was sufficient to rescue both bone density and tail curvature in pkd1a/bknockdown fish (Fig. 7A-D) .
Discussion
The PC1 protein influences a wide variety of signaling pathways, but the downstream effectors that connect PC1 expression to these pathways are largely unknown (3, 5) . A number of studies have suggested that PC1 plays a role in modulating bone formation by regulating the activity of the RunX2 transcription factor, (57, 60) , that disruption of TAZ expression results in the development of renal cystic disease (63, 64) and that the cleaved PC1-CTT interacts with TAZ to promote osteogenesis (62); however, the mechanistic link between PC1 and TAZ had not been fully elucidated. The data presented here demonstrate that the PC1-CTT binds to and activates the transcriptional coactivator TAZ to facilitate PC1-mediated RunX2 activation in the process of bone growth and development. Using a 'coactivator trap' screen, we identified the transcriptional coregulatory protein TAZ as a target of the PC1-CTT. The majority of the transcriptional pathways influenced by the PC1-CTT were inhibited by PC1-CTT expression (12) . Among the short list of transcription factors that were activated by the PC1-CTT, TAZ was the most dramatically stimulated. These data indicate that the PC1-CTT is not simply a general transcriptional repressor, but rather selectively represses some targets while activating others. The results of this initial TF-Gal4 screen were confirmed in HEK293 cells, where the PC1-CTT showed a significant stimulatory effect on TAZ-Gal4. Importantly, TAZGal4 activity was unaffected by expression of the PC1-CTT NLS, which does not translocate into the nucleus. These data indicate that nuclear localization of the PC1-CTT, or at least the presence of the putative NLS, is essential for its regulatory effects on TAZ activity. Taken together with the results of the coactivator trap screen presented here, these observations suggest the interesting possibility that PC1 and TAZ participate in a common physiological pathway.
To assess the activity of the PC1-CTT on RunX2 in the context of bone development, we utilized a mouse mesenchymal stem cell line (C3H10T 1/2 ). These cells have the potential to differentiate into the bone lineage (chondrocytes and osteoblasts) or the fat lineage (adipocytes) (68) . This developmental fate choice is controlled by TAZ, which directs the cells away from the adipocyte lineage (via inhibition of PPARγ ) and toward the chondrocyte/osteoblast lineage (via co-stimulation of RunX2 target genes). Thus, these cells represent a physiologically relevant model in which to assess the regulatory effects of the PC1-CTT on TAZ and RunX2 activity. Furthermore, we employed a RunX2-luciferase reporter construct that facilitated measurement of the activity of endogenous RunX2. Using this reporter construct we observed a decrease in RunX2 activity upon siRNA-mediated knockdown of Pkd1 in the C3H10T 1/2 mesenchymal cell line, which is further substantiated by the recent report demonstrating that endogenously cleaved PC1-CTT, released from fulllength membrane-associated PC1, regulates TAZ/RunX2 activity to stimulate osteogenesis and inhibit adipogenesis in C3H10T
1/2 cells (62). This supports the hypothesis that PC1 plays a crucial role in the process through which RunX2 influences mesenchymal stem cell fate determination, driving them to pursue the chondrocyte and osteoblast lineages. Using the RunX2-luciferase reporter system in C3H10T
1/2 cells, we found that expression of either TAZ or the PC1-CTT alone each induces an increase in endogenous RunX2 activity, and that their co-expression results in a further increase in RunX2 activity. These data are consistent with the possibility that the PC1-CTT may act upstream of TAZ or alternatively that the two proteins could work cooperatively to activate RunX2.
To discriminate among these possibilities we performed siRNAmediated knockdown of TAZ, which abrogated the stimulatory effects of the PC1-CTT on RunX2. This observation indicates that the PC1-CTT requires TAZ for RunX2 activation, and thus that the two proteins are operating sequentially in the same signaling pathway. The PC1-CTT may regulate TAZ via direct binding, as evidenced by our demonstration of a physical complex that involves TAZ and the PC1-CTT. We further narrowed the interacting domain to the last 91 amino acids of PC1, which contains its coiled-coil domain. While the last 91 amino acid residues of PC1 are sufficient to interact with TAZ, they lack the NLS domain that we found to be required in order for the PC1-CTT to exert its influence on TAZ activity. This observation is consistent with the interesting possibility that the PC1-CTT must be present in the nucleus in order for it to modulate TAZ function. Alternatively, the NLS may affect intra-molecular interactions within the structure of the PC1-CTT such that, in its absence, the interaction motif that is present in p91 is unavailable for assembly with TAZ. It is interesting to note that we do not detect any evidence that the PC1-CTT protein expressed in HEK293 cells is further processed to produce the 17 kDa fragment of the PC1 protein (35, 37) . It remains to be determined whether there is any sort of precursor-product relationship between the CTT fragment of PC1 and the smaller 17 kDa fragment of PC1. It is quite possible 17 kDa fragment is not the product of further cleavage of the CTT protein, but rather that both the CTT and the 17 kDa fragment are produced by cleavage directly from the full length PC1 protein. Since 17 kDa fragment overexpression. (A) Morpholinos corresponding to the zebrafish Pkd1a and Pkd1b PC1 or TAZ genes were injected into zebrafish embryos at the 1-2 cell stage to impair expression of the two Pkd1 genes and/or of TAZ. The embryos were subsequently injected with 300nM of mRNA encoding HA-PC1-CTT or TAZ(S89A), where indicated. At 7dpf the embryos were stained for calcified bone using the fluorescent calcein dye dissolved in deionized water, mounted in agarose and imaged. (B) Bone mineralization was quantified on Image-J using thresholded images. The data represent averages of three independent experiments (n = 40-100 embryos per condition); error bars represent standard error of the mean (SEM). (C and D) Morpholinos corresponding to the zebrafish Pkd1a and Pkd1b PC1 or TAZ genes were injected into zebrafish embryos at the 1-2 cell stage to impair expression of the two Pkd1 genes and/or of TAZ. The embryos were subsequently injected with 300nM of mRNA encoding HA-PC1-CTT or TAZ(S89A), where indicated. Images of embryos injected with Pkd1a/b morpholinos alone or followed by injected of mRNA encoding TAZ(S89A) are presented in Panel C. Tail curvature was scored and the results were binned into straight, mild, moderate and severe categories, as previously described (12) . Knockdown of Pkd1a and Pkd1b produce a curly tail phenotype whose severity is partially ameliorated by expression of the PC1-CTT. Loss of TAZ expression prevents the PC1-CTT mediated rescue, but expression of TAZ(S89A) is sufficient to rescue the curly tail phenotype even in the absence of PC1-CTT expression.
should contain the 91 amino acid coiled-coil domain sequence, it will be interesting to assess in future studies whether the 17 kDa protein is capable of interacting with TAZ and, if so, whether this interaction is dependent upon its localization to the nucleus.
The PC1-CTT-HA clearly associates with FLAG-TAZ following immunoprecipitation using anti-FLAG; however, this interaction was not detected with antibodies directed against endogenous TAZ. This may be due to relatively high antibody availabity of the N-terminal FLAG tag versus a possible physical obstruction of the endogenous epitope through the formation of a TAZcontaining multi-protein complex. We have presented evidence that the PC1-CTT significantly increases the association between TAZ and RunX2; however, it is entirely possible that this final protein assembly does not include the PC1-CTT. Rather it may be that the influence of the PC1-CTT on RunX2-TAZ complex formation may be due to its effects on the expression levels and conformation of TAZ and RunX2.
The PC1-CTT robustly associates with TAZ but not with its close homolog YAP, highlighting the specificity of the PC1-CTT-TAZ interaction, and suggesting that the protein domains unique to TAZ may be involved in PC1-CTT binding. In this context it is worth noting that, while YAP and TAZ share overlapping transcriptional targets and regulatory mechanisms, their physiological and pathophysiological properties are clearly not identical. This fact is well illustrated by the renal phenotypes observed in TAZ and YAP knockout mice. Whereas TAZ knockout results in polycystic kidneys (63, 64) , YAP knockout interferes with nephron formation and morphogenesis (76) . Furthermore, YAP activity, as revealed by immunocytochemical detection of nuclear YAP protein, appears to be elevated in a mouse model of ADPKD. These observations suggest the hypothesis that TAZ and YAP may play opposing roles in the processes that lead to renal cyst formation and that the PC1-CTT may serve as a critical factor in determining the relative magnitudes of their respective influences.
In the Hippo signaling pathway the activity of TAZ is regulated by a phosphorylation event that determines this protein's subcellular distribution. Phosphorylation of serine 89 on TAZ promotes its association with 14-3-3, leading to its cytoplasmic retention (44) . The stimulatory effect of the PC1-CTT on RunX2 activity might thus be attributable to promotion of TAZ nuclear import, bringing it into contact with RunX2. To address this hypothesis we examined the localization of TAZ in the presence and absence of the PC1-CTT and found that expression of the PC1-CTT did not cause a dramatic redistribution of TAZ into the nucleus. Furthermore, the PC1-CTT was capable of further stimulating RunX2 activity in the presence of TAZ(S89A). These data suggest that the PC1-CTT stimulates TAZ activity via interactions in the nucleus, rather than by promoting its nuclear redistribution.
The transcriptional activity of RunX2 on its target genes is dependent upon its formation of a complex both with TAZ and with the transcriptional coactivator p300 (48, 70) . Both TAZ and RunX2 have been shown to bind directly to p300 (71, 72) . The data presented here show that PC1-CTT-mediated stimulation of RunX2 is abolished upon knockdown of p300. Furthermore, we found that expression of the PC1-CTT enhances the interaction of TAZ both with p300 and with RunX2, suggesting that the PC1-CTT activates RunX2 by enhancing its ability interact with TAZ and, in turn, to recruit p300.
Studies in zebrafish (74) reveal that PC1 expression plays an important role in bone development and mineralization in this animal model. We took advantage of this system to test whether the PC1-CTT is capable of playing an important role in bone growth and mineralization in vivo. Expression of the PC1-CTT is sufficient to rescue both the jaw bone mineralization defect and the curly tail phenotype produced by morpholino-mediated of knockdown of pkd1a/b expression in zebrafish (74, 75) . Furthermore, both of these rescue effects of PC1-CTT expression are dependent upon the endogenous expression of TAZ and both effects can be recapitulated in the absence of the PC1-CTT by expression of the S89A constitutively active form of TAZ. These data indicate that the PC1-CTT is capable of recapitulating significant components of the activity of full-length PC1 in an in vivo system, highlighting the physiological significance of the PC1-CTT in a living organism.
Previous studies have established the importance of PC1 in RunX2 signaling, but have not illustrated a direct link between the two proteins. Here, we have shown that the PC1-CTT associates with and enhances the activity of TAZ, which in turn stimulates RunX2, possibly via enhanced recruitment of p300. Thus, the evidence presented in this study constitutes a compelling mechanism that accounts for activation of RunX2 by PC1 in the process of bone growth and development. Furthermore, these findings are consistent with the conclusion that TAZ serves as an obligate downstream component of the PC1 protein's effector machinery.
Materials and Methods
Antibodies, plasmids and cell lines
The following antibodies and labeling reagents were used: anti-HA antibody, anti-FLAG and anti-cMyc (Sigma, St. Louis, MO), anti-GST (Amersham Biosciences, Piscataway, NJ), anti-YAP/TAZ (Santa Cruz Biotechnology, Santa Cruz, CA), and anti-14-3-3, anti-TAZ and anti-RunX2 (Cell Signaling, Danvers, MA). For laserscanning confocal fluorescence microscopy, dye-coupled Alexa antibodies (Alexa-488, 594; Molecular Probes, Eugene OR) were used as secondary reagents.
The sequence encoding the final 200 amino acids of human PC1 (4102-4302), containing a 2x HA tag at the N-terminus, was cloned into the pcDNA3.1 zeo vector. The sequence for human PC1-CTT (residues 4102-4302 of Pkd1) was modified by deleting residues 4134-4154, corresponding to the putative NLS to generate the PC1-CTT NLS (33) . Stable cell lines were generated by transfection using Lipofectamine 2000 (Invitrogen, Waltham, MA) and selection with 350 μg ml −1 zeocin (Invitrogen, Waltham, MA). Constructs encoding 3xFLAG-TAZ(WT), 3xFLAG-TAZ(S89A) and 3xFLAG-YAP were purchased from addgene (ID# 24809, #24815, #19045). RunX2-Luciferase (6OSE2-Luc) was a generous gift from Dr Roland Baron and Dr Eric Hesse, Harvard School of Dental Medicine. pRL-TK, a vector constitutively expressing Renilla luciferase, was included as an internal control to normalize for transfection differences. The sequence encoding human p300 (FL or AA 1-664) was cloned from pCMVβ (Upstate Biotechnology, Lake Placid, NY) into the pCMV-Tag 3B vector (Stratagene, La Jolla, California) to generate Myc-p300. HEK293 cells (33) , LLC-PK 1 cells and Pkd1 flox/-and Pkd1 -/-TSLargeT renal proximal tubule cells (67, 77) were maintained as described. C3H10T1/2 mesenchymal stem cells were a generous gift from Dr Roland Baron and Dr Eric Hesse, and were maintained in α-MEM.
Coactivator trap screen
The coactivator trap screen was performed as previously described (66) . A pcDNA3.1 construct expressing HA-PC1-CTT was co-transfected with each of 837 transcription factor-Gal4 fusion proteins and the GAL4 luciferase and Renilla reporter plasmids into HEK293 cells in a 384-well plate. Cells were cultured for 24 h in a humidified incubator at 37
• C in 5% CO2. Proteins were separated on a 10-12% SDS-polyacrylamide gel and then electrophoretically transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA), incubated in blocking buffer (150 mm NaCl, 20 mm Tris, 5% (w/v) powdered milk, 0.1% Tween) for 60 min, and then incubated with one of the following primary antibodies at 4
• C overnight: monoclonal anti-HA (Rat) antibody (1:5000, Roche), polyclonal anti-FLAG (1:5000, Sigma, St. Louis, MO), polyclonal anti-cMyc (1:5000, Sigma, St. Louis, MO), polyclonal anti-GST (Goat) (1:10 000 Amersham Biosciences, Piscataway, NJ) or other antibodies as specified in the text. Subsequently, primary antibody binding was detected using infrared (IR)-conjugated (1:10 000−1:15 000; Li-Cor Biosciences, Lincoln, Nebraska) or horseradish peroxidase-conjugated secondary antibodies (1:5 000-10:000; Jackson Labs, Bar Harbor, ME). Membranes blotted with IRconjugated secondaries were visualized on an Odyssey Infrared Imager (Li-Cor Biosciences, Lincoln, Nebraska) and quantitated using the associated software package; horseradish peroxidase (HRP)-blotted membranes were visualized with an enhanced chemiluminescence detection kit (ECL, Amersham Biosciences, Piscataway, NJ) and quantitated using ImageJ software.
Zebrafish morpholino antisense oligonucleotide injection, mRNA preparation/injections and calcein staining
Morpholino-induced knockdown of pkd1a, pkd1b and TAZ expression was performed as previously reported (48, 74) . Wildtype embryos at the 1-to 2-cell stage were microinjected with 4.6 nl of a 0.15 mm antisense morpholino oligonucleotide dissolved in 1x Daneau buffer (58 mm NaCl, 0.7 mm KCl, 0.4 mm MgSO 4 , 0.6 mm Ca(NO 3 ) 2 , 5 mm HEPES pH 7.6) (Gene Tools LLC, Philomath, OR) with 0.1% Phenol Red using a nanoject2000 microinjector (World Precision Instruments, Sarasota, FL). The sequences of the morpholinos targeting pkd1a and pkd1b were identical to those that have been previously described (74) ; briefly, the splice donor-blocking oligonucleotide sequences were pkd1a MO ex8: 5 -GATCTGAGGACTCACTGTGTGATTT-3 ; pkd1b MO ex45: 5 -ACATGATATTTGTACCTCTTTGGTT-3 . Gene Tools standard negative control morpholino was used as an injection control and demonstrated no effect on development. mRNA encoding 2xHA-PC1-CTT, and TAZ(S89A) were transcribed, using the mMESSAGE mMACHINE Kit (Invitrogen, Waltham, MA), from the corresponding genes inserted into the pCS2 vector.
Calcein staining was performed according to Du et al. (79) . Briefly, embryos at 7dpf were stained by immersion in a 0.2% solution of calcein in deionized water for 10 min, followed by 6× serial washes in water. Embryos were then mounted in acrylamide and imaged using an Olympus BX51 epifluorescent microscope equipped with a 10× objective. Images of the calcein stained bones were background subtracted, thresholded, and the integrated pixel density of the jaw bones was calculated using ImageJ software.
Statistical analysis
Results are expressed as means ± SE. Differences between means were evaluated using Student's t test or analysis of variance as appropriate. Values of P < 0.05 were considered to be significant.
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